Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the operating margin high or low?
The operating margin of -13.78% is 99% above its 5-year average of -1603.46%, near the high end of its 5-year range (-35431.31%–67.95%).
Reported quarterly operating margin; no daily interpolation. Q2 FY2026 (2026-06-30): 0.00%.
OPERATING MARGIN
-13.78%
OPERATING MARGIN AVG TTM
0.00%
OPERATING MARGIN AVG 3Y
-1339.33%
OPERATING MARGIN AVG 5Y
-1603.46%
OPERATING MARGIN AVG 10Y
N/A
OPERATING MARGIN AVG 15Y
N/A
OPERATING MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
+98.97%
CURRENT VS 5Y AVG
+99.14%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 556 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
Century Therapeutics, Inc.
Market Cap
$261.65M
Operating Margin
-13.78%
TTM Avg
0.00%
3Y Avg
-1339.33%
5Y Avg
-1603.46%
Market Cap
$262.00M
Operating Margin
-775.98%
TTM Avg
-556.52%
3Y Avg
-379.20%
5Y Avg
-295.79%
Market Cap
$260.09M
Operating Margin
-4.24%
TTM Avg
-7.03%
3Y Avg
-2.53%
5Y Avg
-5.01%
Market Cap
$262.26M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
-2313.03%
5Y Avg
-2198.82%
Market Cap
$264.73M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
-5599.55%
5Y Avg
-3879.66%
Market Cap
$266.50M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$265.63M
Operating Margin
-1927.32%
TTM Avg
-1059.56%
3Y Avg
-1070.46%
5Y Avg
-779.81%
Market Cap
$248.24M
Operating Margin
-103.99%
TTM Avg
-400.39%
3Y Avg
-200.20%
5Y Avg
-133.47%
Market Cap
$275.02M
Operating Margin
-14.55%
TTM Avg
-6.56%
3Y Avg
-30.72%
5Y Avg
-57.13%
| NAME | MARKET CAP | OPERATING MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Century Therapeutics, Inc. (IPSC) | $261.65M | -13.78% | 0.00% | -1339.33% | -1603.46% |
| EyePoint Pharmaceuticals, Inc. (EYPT)vs › | $262.00M | -775.98% | -556.52% | -379.20% | -295.79% |
| Anika Therapeutics, Inc. (ANIK)vs › | $260.09M | -4.24% | -7.03% | -2.53% | -5.01% |
| Lexeo Therapeutics, Inc. Common Stock (LXEO)vs › | $262.26M | 0.00% | 0.00% | -2313.03% | -2198.82% |
| Inhibikase Therapeutics, Inc. (IKT)vs › | $264.73M | 0.00% | 0.00% | -5599.55% | -3879.66% |
| Eupraxia Pharmaceuticals Inc. (EPRX)vs › | $266.50M | 0.00% | 0.00% | 0.00% | 0.00% |
| AC Immune S.A. (ACIU)vs › | $265.63M | -1927.32% | -1059.56% | -1070.46% | -779.81% |
| Invivyd, Inc. (IVVD)vs › | $248.24M | -103.99% | -400.39% | -200.20% | -133.47% |
| Aurora Cannabis Inc. (ACB)vs › | $275.02M | -14.55% | -6.56% | -30.72% | -57.13% |
| Greenwich LifeSciences, Inc. (GLSI)vs › | $243.66M | 0.00% | 0.00% | 0.00% | 0.00% |
Gross Margin
88.0%
Operating Margin
-13.8%
Operating Margin = Operating Income / Revenue
Operating margin is the percentage of revenue remaining after operating expenses, reflecting operating efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | OPERATING MARGIN |
|---|---|
| 2026-06-30 | 0.00% |
| 2026-03-31 | 0.00% |
| 2025-12-31 | 0.00% |
| 2025-09-30 | 0.00% |
| 2025-06-30 | 0.00% |
| 2025-03-31 | 67.95% |
| 2024-12-31 | -893.46% |
| 2024-09-30 | -4398.10% |
| 2024-06-30 | -4507.78% |
| 2024-03-31 | -3661.87% |
| 2023-12-31 | -16329.10% |
| 2023-09-30 | -24071.62% |
| 2023-06-30 | -35431.31% |
| 2023-03-31 | -1865.17% |
| 2022-12-31 | -6392.71% |
| 2022-09-30 | -1427.07% |
| 2022-06-30 | -2245.77% |
| 2022-03-31 | -3538.37% |
| 2021-12-31 | 0.00% |
| 2021-09-30 | 0.00% |
| 2021-06-30 | 0.00% |
| 2021-03-31 | 0.00% |
| 2020-12-31 | 0.00% |
| 2020-09-30 | 0.00% |
| 2020-06-30 | 0.00% |
| 2020-03-31 | 0.00% |
